ATTEMPTS TO DEVELOP RADIOACTIVE ANTI-CANCER DRUGS

被引:9
|
作者
MITCHELL, JS
BROWN, I
CHIR, B
CARPENTER, RN
机构
关键词
D O I
10.1016/0360-3016(83)90209-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:57 / 59
页数:3
相关论文
共 50 条
  • [1] Anti-cancer drugs
    Bergmann-Leitner, ES
    CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (09) : 1077 - 1078
  • [2] Anti-cancer drugs
    Bergmann-Leitner, Elke
    CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (11) : 1048 - 1048
  • [3] Anti-Cancer Drugs
    Bergmann-Leitner, Elke
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (07) : 730 - 731
  • [4] Teratogens as anti-cancer drugs
    Blagosklonny, MV
    CELL CYCLE, 2005, 4 (11) : 1518 - 1521
  • [5] Development of Anti-cancer Drugs
    Arrondeau, Jennifer
    Gan, Hui K.
    Razak, Albiruni R. A.
    Paoletti, Xavier
    Le Tourneau, Christophe
    DISCOVERY MEDICINE, 2010, 10 (53) : 355 - 362
  • [6] TESTING ANTI-CANCER DRUGS
    不详
    LANCET, 1972, 1 (7755): : 827 - +
  • [7] HANDLING ANTI-CANCER DRUGS
    不详
    LANCET, 1983, 1 (8323): : 543 - 543
  • [8] Anti-cancer drugs for cardioprotection
    Wu, Nan
    Xie, Yizhen
    Yang, Burton B.
    CELL CYCLE, 2017, 16 (02) : 155 - 156
  • [9] TESTING ANTI-CANCER DRUGS
    BERENBAUM, MC
    SHEARD, CE
    LANCET, 1972, 1 (7760): : 1116 - +
  • [10] Improved anti-cancer drugs
    Barden, D
    DALTON TRANSACTIONS, 2005, (11) : C42 - C42